drugset / Trial / NCT05014373
Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19
Phase 3
Unknown
144 enrolled
University of the Philippines
Department of Health, Philippines · collab
RandomizedParallel-groupOpen-labelSupportive care
Summary
This is an open label randomized controlled clinical trial which was designed to confirm the potential efficacy and safety of favipiravir in the management of patients with mild to moderate COVID-19 compared to best supportive care.
Timeline
- Start
- 2020-10-12
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Favipiravir | Small molecule | 800 mg | Oral |